There is a significant association between EGFR mutation and the risk of BMs at the time of initial diagnosis in advanced lung cancer, and there is a high adjusted odds ratio (3.83) between EGFR mutation and the risk of BMs at the time of follow-up after curative resection for LUAD 4,5. Here, EGFR is linked to lung cancer.